Publications by authors named "Ignacio Tagarro"

Claim this Profile
E
EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumor necrosis factor-α as first- or second-line biologic treatment among patients with ulcerative colitis.
Francesc Casellas, Ana Gutiérrez-Casbas, Cristina Rodríguez, Javier P Gisbert, Sabino Riestra, Ignacio Tagarro

Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot study.
Fernando Gomollón, Javier P Gisbert, Iván Guerra, Rocío Plaza, Ramón Pajares Villarroya, Ignacio Tagarro

Eur J Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Natural Language Processing for the Identification of Crohn Disease-Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD Project.
Carmen Montoto, Javier P Gisbert, Iván Guerra, Rocío Plaza, Ramón Pajares Villarroya, Ignacio Tagarro

JMIR Med Inform· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study.
Ignacio Marin-Jimenez, Guillermo Bastida, Ana Forés, Esther Garcia-Planella, Federico Argüelles-Arias, Ignacio Tagarro

BMJ Open Gastroenterol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.
Damián García-Olmo, Gert Van Assche, Ignacio Tagarro, Mary Carmen Diez, Marie Paule Richard

Adv Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis.
David A Schwartz, Ignacio Tagarro, Mary Carmen Díez, William J Sandborn

Inflamm Bowel Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
Julián Panés, Damián García-Olmo, Gert Van Assche, Jean Frederic Colombel, Walter Reinisch, Ignacio Tagarro

Gastroenterology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial.
Jose M Álvaro-Gracia, Juan A Jover, Rosario García-Vicuña, Luis Carreño, Alberto Alonso, Ignacio Tagarro

Ann Rheum Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tramadol SR Formulations : Pharmacokinetic Comparison of a Multiple-Units Dose (Capsule) versus a Single-Unit Dose (Tablet).
Peter J Cnota, Horst Nowak, Ignacio Tagarro, Katharina Erb, Michael Schürer

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole.
Antonio Gigante, Ignacio Tagarro

Clin Drug Investig· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
Andrew L Finn, Niraj Vasisht, Jeffrey G Stark, Larry N Gever, Ignacio Tagarro

Clin Drug Investig· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
Andrew L Finn, Niraj Vasisht, Jeffrey G Stark, Larry N Gever, Ignacio Tagarro

Clin Drug Investig· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.
Frank Elsner, Giovambattista Zeppetella, Josep Porta-Sales, Ignacio Tagarro

Clin Drug Investig· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis.
Andrew L Finn, Wd Charlie Hill, Ignacio Tagarro, Larry N Gever

J Pain Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra- and interindividual variabilities in the pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a cross-study analysis.
Andrew Davies, Andrew Finn, Ignacio Tagarro

Clin Drug Investig· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.
Niraj Vasisht, Larry N Gever, Ignacio Tagarro, Andrew L Finn

J Clin Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics of fentanyl buccal soluble film.
Niraj Vasisht, Larry N Gever, Ignacio Tagarro, Andrew L Finn

Pain Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
Niraj Vasisht, Larry N Gever, Ignacio Tagarro, Andrew L Finn

Clin Drug Investig· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic assessment of a fast-release orodispersible tramadol tablet compared to a conventional tramadol capsule.
Ignacio Tagarro, Francoise Vauzelle-Kervroedan, Mary Carmen Díez

Arzneimittelforschung· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis